Ignite Creation Date:
2024-05-06 @ 1:49 AM
Last Modification Date:
2024-10-26 @ 11:10 AM
Study NCT ID:
NCT01909453
Status:
COMPLETED
Last Update Posted:
2024-04-26
First Post:
2013-07-24
Brief Title:
Study Comparing Combination of LGX818 Plus MEK162 Versus Vemurafenib and LGX818 Monotherapy in BRAF Mutant Melanoma
Sponsor:
Organization:
Pfizer